Cargando…

Circulating Autoantibodies to LGALS3BP: A Novel Biomarker for Cancer

Purpose. Circulating autoantibodies have been extensively investigated as possible markers for early diagnosis of cancer. The present study was carried out to investigate whether anti-LGALS3BP IgG autoantibodies could be classified as a biomarker for malignant tumors. Methods. An in-house developed...

Descripción completa

Detalles Bibliográficos
Autores principales:	Grassadonia, Antonino, Tinari, Nicola, Natoli, Clara, Yahalom, Galit, Iacobelli, Stefano
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3850626/ https://www.ncbi.nlm.nih.gov/pubmed/24347795 http://dx.doi.org/10.1155/2013/214595

Ejemplares similares

Prognostic relevance of LGALS3BP in human colorectal carcinoma
por: Piccolo, Enza, et al.
Publicado: (2015)

Targeting Vesicular LGALS3BP by an Antibody-Drug Conjugate as Novel Therapeutic Strategy for Neuroblastoma
por: Capone, Emily, et al.
Publicado: (2020)

Breast cancer follow-up strategies in randomized phase III adjuvant clinical trials: a systematic review
por: Sperduti, Isabella, et al.
Publicado: (2013)

Breast Cancer “Tailored Follow-up” in Italian Oncology Units: A Web-Based Survey
por: Natoli, Clara, et al.
Publicado: (2014)

Extracellular LGALS3BP: a potential disease marker and actionable target for antibody–drug conjugate therapy in glioblastoma
por: Dufrusine, Beatrice, et al.
Publicado: (2023)

LGALS3BP: A Potential Plasma Biomarker Associated with Diagnosis and Prognosis in Patients with Sepsis
por: Luo, Meiyan, et al.
Publicado: (2021)

Prognostic value of a novel circulating serum 90K antigen in breast cancer.
por: Iacobelli, S., et al.
Publicado: (1994)

Meta-analysis of phase III trials of docetaxel alone or in combination with chemotherapy in metastatic breast cancer
por: Belfiglio, Maurizio, et al.
Publicado: (2011)

Alectinib Induced Regression of Renal and Hepatic Cysts Caused by Crizotinib
por: Di Marino, Pietro, et al.
Publicado: (2020)

The Antiviral Activity of the Cellular Glycoprotein LGALS3BP/90K Is Species Specific
por: Lodermeyer, Veronika, et al.
Publicado: (2018)

90K/LGALS3BP expression is upregulated in COVID-19 but may not restrict SARS-CoV-2 infection
por: Bosquillon de Jarcy, Laure, et al.
Publicado: (2023)

Effect of Targeted Agents on the Endocrine Response of Breast Cancer in the Neoadjuvant Setting: A Systematic Review
por: Grassadonia, Antonino, et al.
Publicado: (2015)

A Case of Stage I Vulvar Squamous Cell Carcinoma with Early Relapse and Rapid Disease Progression
por: Peri, Marta, et al.
Publicado: (2019)

Investigating LGALS3BP/90 K glycoprotein in the cerebrospinal fluid of patients with neurological diseases
por: Costa, Júlia, et al.
Publicado: (2020)

Extracellular LGALS3BP regulates neural progenitor position and relates to human cortical complexity
por: Kyrousi, Christina, et al.
Publicado: (2021)

Long-Term Outcome of Neoadjuvant Endocrine Therapy with Aromatase Inhibitors in Elderly Women with Hormone Receptor-Positive Breast Cancer
por: Grassadonia, Antonino, et al.
Publicado: (2014)

LGALS3BP in Microglia Promotes Retinal Angiogenesis Through PI3K/AKT Pathway During Hypoxia
por: Zhao, Chenyang, et al.
Publicado: (2022)

Long-term outcome of neoadjuvant systemic therapy for locally advanced breast cancer in routine clinical practice
por: Angelucci, Domenico, et al.
Publicado: (2012)

Lgals3bp suppresses colon inflammation and tumorigenesis through the downregulation of TAK1-NF-κB signaling
por: Cho, Sang-Hee, et al.
Publicado: (2021)

Inducible LGALS3BP/90K activates antiviral innate immune responses by targeting TRAF6 and TRAF3 complex
por: Xu, Gang, et al.
Publicado: (2019)

Effectiveness of neoadjuvant trastuzumab and chemotherapy in HER2-overexpressing breast cancer
por: Natoli, Clara, et al.
Publicado: (2013)

Circulating Cancer Stem Cell-Derived Extracellular Vesicles as a Novel Biomarker for Clinical Outcome Evaluation
por: Brocco, D., et al.
Publicado: (2019)

Prognostic Relevance of Neutrophil to Lymphocyte Ratio (NLR) in Luminal Breast Cancer: A Retrospective Analysis in the Neoadjuvant Setting
por: Grassadonia, Antonino, et al.
Publicado: (2021)

Corrigendum to “Circulating Cancer Stem Cell-Derived Extracellular Vesicles as a Novel Biomarker for Clinical Outcome Evaluation”
por: Brocco, D., et al.
Publicado: (2020)

Gal-3BP in Viral Infections: An Emerging Role in Severe Acute Respiratory Syndrome Coronavirus 2
por: Gallo, Valentina, et al.
Publicado: (2022)

Validation of Salivary Markers, IL-1β, IL-8 and Lgals3bp for Detection of Oral Squamous Cell Carcinoma in an Indian Population
por: Singh, Prerana, et al.
Publicado: (2020)

Suppression of triple-negative breast cancer aggressiveness by LGALS3BP via inhibition of the TNF-α–TAK1–MMP9 axis
por: Sun, Eun-Gene, et al.
Publicado: (2023)

Immunological effects of alternative weekly interferon-alpha-2b and low dose interleukin-2 in patients with cancer.
por: Fiorentino, B., et al.
Publicado: (1992)

Effect of Gender on the Outcome of Patients Receiving Immune Checkpoint Inhibitors for Advanced Cancer: A Systematic Review and Meta-Analysis of Phase III Randomized Clinical Trials
por: Grassadonia, Antonino, et al.
Publicado: (2018)

Role of Hydroxamate-Based Histone Deacetylase Inhibitors (Hb-HDACIs) in the Treatment of Solid Malignancies
por: Grassadonia, Antonino, et al.
Publicado: (2013)

The Role of Dysfunctional Adipose Tissue in Pancreatic Cancer: A Molecular Perspective
por: Brocco, Davide, et al.
Publicado: (2020)

SREBP1 regulates Lgals3 activation in response to cholesterol loading
por: Li, Jing, et al.
Publicado: (2022)

Increased Gal-3BP plasma levels in hospitalized patients infected with SARS-CoV-2
por: Gallo, Valentina, et al.
Publicado: (2022)

The significance of preclinical anti-BP180 autoantibodies
por: Mai, Yosuke, et al.
Publicado: (2022)

Upregulation of LGALS1 is associated with oral cancer metastasis
por: Li, Ji-Min, et al.
Publicado: (2018)

Enhanced cortical bone expansion in Lgals3-deficient mice during aging
por: Maupin, Kevin A., et al.
Publicado: (2018)

Circular RNA circARHGEF28 inhibited the progression of prostate cancer via the miR‐671‐5p/LGALS3BP/NF‐κB axis
por: Guo, Kaixuan, et al.
Publicado: (2023)

Comprehensive Analysis of Immunoinhibitors Identifies LGALS9 and TGFBR1 as Potential Prognostic Biomarkers for Pancreatic Cancer
por: Fan, Yue, et al.
Publicado: (2020)

Neoadjuvant Immune-Checkpoint Blockade in Triple-Negative Breast Cancer: Current Evidence and Literature-Based Meta-Analysis of Randomized Trials
por: Marinelli, Daniele, et al.
Publicado: (2020)

Impact of primary tumor location in patients with RAS wild-type metastatic colon cancer treated with first-line chemotherapy plus anti-EGFR or anti-VEGF monoclonal antibodies: a retrospective multicenter study
por: Grassadonia, Antonino, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ngjailqp0anf22s5899if79eck